Drug Repackager To Halt Practices After FDA Mislabeling Suit
The U.S. Food and Drug Administration and an Ohio drug repackaging company have struck a deal that will prevent the company from resuming its repackaging and redistributing activities until it proves...To view the full article, register now.
Already a subscriber? Click here to view full article